Pharmagreen Biotech Valuation
| PHBI Stock | USD 0 0.0002 11.76% |
Pharmagreen Biotech seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Pharmagreen Biotech from analyzing the company fundamentals such as Net Income of (875.48 K), return on asset of -2.3, and Shares Owned By Insiders of 18.63 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Pharmagreen Biotech's price fluctuation is out of control at this time. Calculation of the real value of Pharmagreen Biotech is based on 3 months time horizon. Increasing Pharmagreen Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Pharmagreen Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pharmagreen Pink Sheet. However, Pharmagreen Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0015 | Real 0.00144 | Hype 0.001717 | Naive 0.001611 |
The intrinsic value of Pharmagreen Biotech's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Pharmagreen Biotech's stock price.
Estimating the potential upside or downside of Pharmagreen Biotech helps investors to forecast how Pharmagreen pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharmagreen Biotech more accurately as focusing exclusively on Pharmagreen Biotech's fundamentals will not take into account other important factors: Pharmagreen Biotech Total Value Analysis
Pharmagreen Biotech is at this time forecasted to have valuation of 3.12 M with market capitalization of 2.96 M, debt of 119.47 K, and cash on hands of 24.26 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Pharmagreen Biotech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.12 M | 2.96 M | 119.47 K | 24.26 K |
Pharmagreen Biotech Asset Utilization
One of the ways to look at asset utilization of Pharmagreen is to check how much profit was generated for every dollar of assets it reports. Pharmagreen Biotech holds a negative application of assets of -2.3 pct., losing $0.023 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Pharmagreen Biotech shows how discouraging it operates for each dollar spent on its assets.Pharmagreen Biotech Ownership Allocation
Pharmagreen Biotech owns a total of 454.76 Million outstanding shares. Pharmagreen Biotech holds 18.63 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Pharmagreen Biotech Profitability Analysis
Net Loss for the year was (875.48 K) with profit before overhead, payroll, taxes, and interest of 0.About Pharmagreen Biotech Valuation
An absolute valuation paradigm, as applied to Pharmagreen Pink Sheet, attempts to find the value of Pharmagreen Biotech based on its fundamental and basic technical indicators. By analyzing Pharmagreen Biotech's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Pharmagreen Biotech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pharmagreen Biotech. We calculate exposure to Pharmagreen Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pharmagreen Biotech's related companies.Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada. Pharmagreen Biotech is traded on OTC Exchange in the United States.
8 Steps to conduct Pharmagreen Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Pharmagreen Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pharmagreen Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pharmagreen Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pharmagreen Biotech's revenue streams: Identify Pharmagreen Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pharmagreen Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pharmagreen Biotech's growth potential: Evaluate Pharmagreen Biotech's management, business model, and growth potential.
- Determine Pharmagreen Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pharmagreen Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Pharmagreen Biotech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 442.3 M | |
| Retained Earnings | -12.6 M | |
| Shares Float | 370 M |
Complementary Tools for Pharmagreen Pink Sheet analysis
When running Pharmagreen Biotech's price analysis, check to measure Pharmagreen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagreen Biotech is operating at the current time. Most of Pharmagreen Biotech's value examination focuses on studying past and present price action to predict the probability of Pharmagreen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagreen Biotech's price. Additionally, you may evaluate how the addition of Pharmagreen Biotech to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |